📅 We're counting down until #ELCC25 kicks off in Paris tomorrow! ⭐ In the meantime, don't miss our interview with @StephenVLiu of @Georgetown, @LombardiCancer, who discusses key highlights of the upcoming meeting. ➡️ Watch: https://t.co/PAZy6HeNyK #lcsm #LungCancer https://t.co/KgVlbwQQHX

🌅 Today's the day! ⭐ The European Lung Cancer Congress kicks off in Paris with the opening session and Heine H. Hansen Award at 1:50 p.m. CET! ➡️ Follow us and stay tuned for our #ELCC25 coverage here: https://t.co/0gJfnJW8xQ #ELCC2025 #lcsm #LungCancer @myESMO @IASLC https://t.co/nwAxWZQP2d

👏 Congratulations to Professor Keith Kerr of @NHSGrampian, @aberdeenuni, for receiving the Heine H. Hansen Award at #ELCC25! ➡️ Don't miss our coverage of his insightful award lecture: https://t.co/alEGkW7Trq @myESMO @ResearchAwaren1 @register4share #ELCC2025 https://t.co/cBWCuD07dy

🫁 The updated OS data from #LAURA “further substantiate the fact that osimertinib after definitive chemoradiotherapy is the new standard of care," @RamalingamMD of @WinshipAtEmory said during his presentation at #ELCC25. ➡️ Learn more: https://t.co/ONeag1m0tp #lcsm #NSCLC https://t.co/qho5uK6ahG

🦋 It's been an exciting first day of #ELCC25 with the much-anticipated presentation of final OS results from MARIPOSA! ⭐ Don't miss this insightful interview with @nicogirardcurie, who weighs in on the data & implications! ➡️ Watch: https://t.co/APEK1SVro3 #NSCLC #lcsm https://t.co/nMPqZxVXAr

🤩 Wow! What an amazing #ELCC25! ⏰ We're already counting down til next year! ➡️ In the meantime, catch up on #ELCC2025 news here - from #MARIPOSA to #LAURA, we've got it covered: https://t.co/0gJfnJW8xQ #lcsm #NSCLC #SCLC #lungcancer https://t.co/dlYF5rCpFh